您当前的位置:
首页 >
文章列表页 >
Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway
更新时间:2025-01-24
    • Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway

    • The latest research has found that the modified Guishen Pill effectively improves ovarian function and has anti-inflammatory effects in polycystic ovary syndrome rats by inhibiting the MAPK/NF - κ B pathway.
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 5, Pages: 86-94(2025)
    • DOI:10.13422/j.cnki.syfjx.20241842    

      CLC: R285;R242;R271
    • Received:26 August 2024

      Accepted:06 November 2024

      Published Online:07 November 2024

      Published:05 March 2025

    移动端阅览

  • TIAN Jiayu,QIN Wenyi,YANG Juan,et al.Modified Guishenwan Alleviates Inflammation in Rat Model of Polycystic Ovary Syndrome by Inhibiting MAPK/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(05):86-94. DOI: 10.13422/j.cnki.syfjx.20241842.

  •  
  •  

0

Views

22

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of Modified Guishenwan in Regulating AMPK/Akt/Nrf2 Pathway to Improve Glucose and Lipid Metabolism and Oxidative Stress in Polycystic Ovary Syndrome Rats
Research of Influence on Inflammation of Xieheyin on PCOS-IR Mice Based on Intestinal Mucosal Barrier and TLR4/NF-κB/NLRP3 Pathway
Exploring Mechanism of Kelong Capsules in Treatment of Benign Prostatic Hyperplasia Based on Nrf2 Pathway and Macrophage Activation

Related Author

QIN Wenyi
YANG Juan
Xue-fei XU
En-li WANG
Tian-ye YANG
Jing-chun YAO
Xin GONG
Wen-yue CHEN

Related Institution

Affiliated Hospital of Nanjing University of Chinese Medicine
State Key Laboratory of Generic Manufacture Technology of Traditional Chinese Medicine
The First Clinical Medical College of Shaanxi University of Chinese Medicine
Experimental Research Center,China Academy of Chinese Medical Sciences
Beijing University of Chinese Medicine
0